-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NYUKHD0ShzVPKT8k3VHf6lnfZLJ4w26UcbQHBt5Xm/tDTzDu8qePXuztQgCSyZEn y7jfc+0W9qKC/APIsxsCug== 0000897101-04-001602.txt : 20040817 0000897101-04-001602.hdr.sgml : 20040817 20040817170547 ACCESSION NUMBER: 0000897101-04-001602 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040816 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ST JUDE MEDICAL INC CENTRAL INDEX KEY: 0000203077 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411276891 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12441 FILM NUMBER: 04982518 BUSINESS ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 BUSINESS PHONE: 6514832000 MAIL ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 8-K 1 stjude043951_8k.htm St. Jude Medical, Inc. Form 8-K dated August 16, 2004

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported)   August 16, 2004



ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its chapter)


Minnesota
(State or other jurisdiction
of incorporation)

0-8672


(Commission
File Number)

41-1276891
(IRS Employer
Identification No.)



One Lillehei Plaza, St. Paul, MN
(Address of principal executive offices)

55117
(Zip Code)



Registrant’s telephone number, including area code (651) 483-2000


Not applicable
(Former name or former address, if changed since last report)






Item 9.  Regulation FD Disclosure


On August 16, 2004, the registrant issued a press release concerning a share repurchase program of up to $300 million of its outstanding common stock; a copy of which is furnished herewith as Exhibit 1.


SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



ST. JUDE MEDICAL, INC.



Date:  August 17, 2004

By: /s/   Kevin T. O’Malley            

Kevin T. O’Malley

Vice President and

General Counsel







                                                        EXHIBIT INDEX


Exhibit                                            Description of Exhibit


    1                                                 Press Release, dated August 16, 2004










 EX-99.1 2 stjude043951_ex99-1.htm Exhibit 99.1 to St. Jude Medical, Inc. Form 8-K dated August 16, 2004


Exhibit 1


St. Jude Medical Board of Directors Authorizes Share Repurchase


St. Paul, MN, August 16, 2004 — St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase program of up to $300 million of its outstanding common stock. The authorization expires on December 31, 2006. The repurchases will occur at such times and at such prices as the management of the Company determines and may be effected through transactions in the open market, in privately negotiated transactions or in derivative transactions. The share repurchase program will be funded by the Company’s existing commercial paper program.


St. Jude Medical, Inc. (www.sjm.com) is dedicated to the design, manufacture and distribution of innovative medical devices of the highest quality, offering physicians, patients and payers unmatched clinical performance and demonstrated economic value.

















 -----END PRIVACY-ENHANCED MESSAGE-----